Literature DB >> 1206674

Avascular necrosis and its relation to lipid and purine metabolism.

H Mielants, E M Veys, A DeBussere, J van der Jeught.   

Abstract

Serum uric acid, triglycerides, cholesterol, and lipoprotein levels were determined in 35 patients with primary avascular necrosis of the femoral head. The results were compared with a control group and a group of gouty patients. Frequency distribution of the data in the three groups was found to be of the log normal type, and the statistical calculations were performed after log transformation of the serum values. Compared to the control group, a significant increase in the levels of triglycerides, cholesterol, pre-beta-lipoprotein, and uric acid were found in the patients with avascular necrosis. No significant difference was observed between lipid and lipoprotein levels in gout and avascular necrosis, although the serum uric acid was higher in the gouty patients. In contrast to the findings in gout, the uric acid levels did not correlate with the lipid or lipoprotein fractions in patients with avascular necrosis. There were no statistical differences between lipid, lipoprotein and uric acid levels in patients with avascular necrosis receiving corticosteroids or using alcohol, as compared with those not taking these drugs. It is concluded that avascular necrosis of bone complicating longterm use of steroids or alcohol is not induced directly by the two drugs, but that the initiating event may lie in lipid disturbances.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1206674

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Case report 763. Osteonecrosis and gout of femoral head.

Authors:  A Cooper; R Minutello; V J Vigorita; E Bryk
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  [Twelve theses on the pathogenesis of primary and secondary osteoporosis based on histological observations].

Authors:  R Burkhardt; R Bartl; K Demmler; G Kettner
Journal:  Klin Wochenschr       Date:  1981-01-02

Review 3.  Subchondral avascular necrosis: a common cause of arthritis.

Authors:  P G Bullough; E F DiCarlo
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

4.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.

Authors:  J Calvo-Alén; G McGwin; S Toloza; M Fernández; J M Roseman; H M Bastian; E J Cepeda; E B González; B A Baethge; B J Fessler; L M Vilá; J D Reveille; G S Alarcón
Journal:  Ann Rheum Dis       Date:  2005-11-03       Impact factor: 19.103

5.  Histopathology of femoral head osteonecrosis in rheumatoid arthritis: the relationship between steroid therapy and lipid degeneration in the osteocyte.

Authors:  Y Watanabe; K Kawai; K Hirohata
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

6.  The impact of high total cholesterol and high low-density lipoprotein on avascular necrosis of the femoral head in low-energy femoral neck fractures.

Authors:  Xianshang Zeng; Ke Zhan; Lili Zhang; Dan Zeng; Weiguang Yu; Xinchao Zhang; Mingdong Zhao; Zhicheng Lai; Runzhen Chen
Journal:  J Orthop Surg Res       Date:  2017-02-17       Impact factor: 2.359

7.  Significant association of SREBP-2 genetic polymorphisms with avascular necrosis in the Korean population.

Authors:  Tae-Ho Kim; Jeong-In Baek; Jung Min Hong; Su-Jin Choi; Hye-Jin Lee; Hyun-Ju Cho; Eui Kyun Park; Un-Kyung Kim; Shin-Yoon Kim
Journal:  BMC Med Genet       Date:  2008-10-27       Impact factor: 2.103

8.  Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population: Results from a Nationally Representative Survey.

Authors:  De-Wei Zhao; Mang Yu; Kai Hu; Wei Wang; Lei Yang; Ben-Jie Wang; Xiao-Hong Gao; Yong-Ming Guo; Yong-Qing Xu; Yu-Shan Wei; Si-Miao Tian; Fan Yang; Nan Wang; Shi-Bo Huang; Hui Xie; Xiao-Wei Wei; Hai-Shen Jiang; Yu-Qiang Zang; Jun Ai; Yuan-Liang Chen; Guang-Hua Lei; Yu-Jin Li; Geng Tian; Zong-Sheng Li; Yong Cao; Li Ma
Journal:  Chin Med J (Engl)       Date:  2015-11-05       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.